» Authors » Christopher T Bever Jr

Christopher T Bever Jr

Explore the profile of Christopher T Bever Jr including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 810
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Makar T, Guda P, Ray S, Andhavarapu S, Keledjian K, Gerzanich V, et al.
Sci Rep . 2023 Apr; 13(1):5635. PMID: 37024509
Endoplasmic reticulum (ER) stress and mitochondrial dysfunction are found in lesions of multiple sclerosis (MS) and animal models of MS such as experimental autoimmune encephalomyelitis (EAE), and may contribute to...
2.
Conroy S, Harcum S, Keldsen L, Bever Jr C
J Telemed Telecare . 2020 Sep; 28(5):380-388. PMID: 32869689
NCT02665052. Registered 27 January 2016. https://clinicaltrials.gov/ct2/show/NCT02665052.
3.
Kilbourne A, Braganza M, Bowersox N, Goodrich D, Miake-Lye I, Floyd N, et al.
Med Care . 2019 Sep; 57 Suppl 10 Suppl 3:S206-S212. PMID: 31517789
Background: US health care systems face a growing demand to incorporate innovations that improve patient outcomes at a lower cost. Funding agencies increasingly must demonstrate the impact of research investments...
4.
Makar T, Nimmagadda V, Guda P, Hampton B, Huang W, Kane M, et al.
Stem Cell Res Ther . 2018 May; 9(1):127. PMID: 29720239
Background: Adult bone marrow contains stem cells that replenish the myeloid and lymphoid lineages. A subset of human and mouse CD34 bone marrow stem cells can be propagated in culture...
5.
Hugos C, Chen Z, Chen Y, Turner A, Haselkorn J, Chiara T, et al.
Mult Scler . 2017 Dec; 25(2):275-285. PMID: 29226778
Background: Fatigue occurs in 75%-95% of people with multiple sclerosis (MS) and is frequently reported as the most disabling symptom. A multicomponent group program of six weekly 2-hour sessions, Fatigue:...
6.
Sigsbee B, Goldenberg J, Bever Jr C, Schierman B, Jones Jr L
Neurology . 2016 Oct; 87(21):2254-2258. PMID: 27694258
Clinical quality data registries are increasingly popular tools used by providers to improve the quality of clinical care and satisfy growing numbers of regulatory and reporting requirements. Specialty societies use...
7.
Nimmagadda V, Makar T, Chandrasekaran K, Sagi A, Ray J, Russell J, et al.
J Neuroimmunol . 2016 Jul; 304:29-34. PMID: 27474445
Neurodegeneration is an important determinant of disability in multiple sclerosis (MS) but while currently approved treatments reduce inflammation, they have not been shown to reduce neurodegeneration. SIRT1, a NAD dependent...
8.
Bever Jr C, Wallin M
Mult Scler . 2016 Mar; 22(3):267-8. PMID: 26951816
No abstract available.
9.
Makar T, Nimmagadda V, Singh I, Lam K, Mubariz F, Judge S, et al.
J Neuroimmunol . 2016 Mar; 292:9-20. PMID: 26943953
7,8-Dihydroxyflavone (DHF), is a recently described TrkB agonist that readily crosses the blood brain barrier. We treated C57Bl/6 mice with MOG--induced EAE daily with DHF starting on the day of...
10.
Sigsbee B, Bever Jr C, Jones Jr L
Neurology . 2015 Nov; 86(2):188-93. PMID: 26519541
Increasing emphasis on improving health care quality has led to a variety of programs that require neurologists to be familiar with the concept of systematic quality improvement. While they vary...